Biogen (NASDAQ: BIIB) disclosed in an SEC filing:
On August 2, 2018, the Board of Directors of Biogen Inc. (the “Company”) authorized a program to repurchase up to $3.5 billion of the Company’s common stock (the “2018 Share Repurchase Program”). The 2018 Share Repurchase Program does not have an expiration date. All share repurchases under the 2018 Share Repurchase Program will be retired.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.